Boothbay Fund Management, LLC Verrica Pharmaceuticals Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 2,807,346 shares of VRCA stock, worth $22.3 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
2,807,346
Previous 2,587,046
8.52%
Holding current value
$22.3 Million
Previous $20.6 Million
8.51%
% of portfolio
0.68%
Previous 0.63%
Shares
3 transactions
Others Institutions Holding VRCA
# of Institutions
73Shares Held
20.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.57MShares$68.1 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$8.1 Million0.0% of portfolio
-
Ubs Group Ag790KShares$6.28 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...